Insider · CIK 0001266567
ATWOOD BRIAN G
Reports to the SEC for 20 companies · SOUTH SAN FRANCISCO, CA
Transactions
50
Companies
20
Filings
10
CIK
0001266567
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-07 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-05-30 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-03-31 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Pre-Funded WarrantM Exercise/Conversion | +$29.446 |
| 2025-03-31 | CEROCERO THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion | +$29.446 |
| 2025-03-04 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-02-24 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-02-07 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Pre-Funded WarrantA Award | +$20.408 |
| 2025-02-07 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Pre-Funded WarrantA Award | +$30.612 |
| 2025-02-07 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Warrant to Purchase Shares of Common StockA Award | +$600K |
| 2025-02-07 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Warrant to Purchase Shares of Common StockA Award | +$400K |
| 2024-12-02 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-09-30 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-09-30 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-09-25 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockM Exercise/Conversion | −$1M |
| 2024-09-25 | CEROCERO THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion | — |
| 2024-03-25 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockA Award | +$1M |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockA Award | +$1M |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Series A Convertible Preferred StockA Award | +$1M |
| 2024-02-14 | CEROCERO THERAPEUTICS HOLDINGS, INC.J Other | — |
| 2023-06-13 | Atreca, Inc.Stock Option (right to buy)A Award | — |
| 2022-06-08 | Atreca, Inc.Stock Option (right to buy)A Award | — |
| 2021-10-08 | CEROCERO THERAPEUTICS HOLDINGS, INC. · Class B Common StockJ Other | — |
| 2021-06-10 | Clovis Oncology, Inc.Stock Option (right to buy)A Award | — |
| 2021-06-09 | Atreca, Inc.Stock Option (right to buy)A Award | — |
| 2021-01-12 | eFFECTOR Therapeutics, Inc.Class B Common StockJ Other | — |
| 2020-12-09 | Atreca, Inc.Stock Option (right to buy)G Gift | — |
| 2020-12-09 | Atreca, Inc.Stock Option (right to buy)G Gift | — |
| 2020-12-09 | Atreca, Inc.Stock Option (right to buy)G Gift | — |
| 2020-12-09 | Atreca, Inc.Stock Option (right to buy)G Gift | — |
| 2020-12-09 | Atreca, Inc.Stock Option (right to buy)G Gift | — |
| 2020-12-09 | Atreca, Inc.Stock Option (right to buy)G Gift | — |
| 2020-11-09 | Clovis Oncology, Inc.M Exercise/Conversion | +$21.2K |
| 2020-11-09 | Clovis Oncology, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-06-10 | Atreca, Inc.Stock Option (right to buy)A Award | — |
| 2020-06-04 | Clovis Oncology, Inc.Stock Option (right to buy)A Award | — |
| 2019-08-20 | Clovis Oncology, Inc.M Exercise/Conversion | +$7,499.98 |
| 2019-08-20 | Clovis Oncology, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-06-24 | Atreca, Inc.Series B Preferred StockC Conversion | — |
| 2019-06-24 | Atreca, Inc.Series A Preferred StockC Conversion | — |
| 2019-06-24 | Atreca, Inc.C Conversion | — |
| 2019-06-06 | Clovis Oncology, Inc.Stock Option (right to buy)A Award | — |
| 2018-10-11 | Clovis Oncology, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4ATWOOD BRIAN G0001213900-26-002951SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-25-050113SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-25-029111SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-25-021183SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-25-017505SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-25-011409SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-24-105726SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-24-084829SEC(opens sec.gov)
- 4ATWOOD BRIAN G0001213900-24-026814SEC(opens sec.gov)
- 4/AATWOOD BRIAN G0001213900-24-021525SEC(opens sec.gov)
Companies
- Atreca, Inc.Director
- CADENCE PHARMACEUTICALS INCDirector
- CapForce Inc.Director, 10% OwnerCFOR
- CERO THERAPEUTICS HOLDINGS, INC.DirectorCERO
- Clovis Oncology, Inc.Director
- eFFECTOR Therapeutics, Inc.Director
- FIVE PRIME THERAPEUTICS, INC.Director
- Flexion Therapeutics Inc10% Owner
- GENOMIC HEALTH INC10% Owner
- GLAUKOS Corpformer 10% holderGKOS
- HELICOS BIOSCIENCES CORPDirector, 10% Owner
- IMMUNE DESIGN CORP.Director
- Inogen Inc10% OwnerINGN
- Launch One Acquisition Corp.DirectorLPAA
- PHARMION CORPDirector
- PHASERX, INC.Director, 10% Owner
- Trius Therapeutics IncDirector
- VERACYTE, INC.Director, 10% OwnerVCYT
- Vivani Medical, Inc.10% OwnerVANI
- XENOGEN CORPDirector
Address
CERO THERAPEUTICS HOLDINGS, INC. 201 HASKINS WAY, SUITE 230
SOUTH SAN FRANCISCO, CA, 94080